These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2817800)

  • 1. Antitumoral effects of lipopolysaccharides, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution.
    Chokri M; Freudenberg M; Galanos C; Poindron P; Bartholeyns J
    Anticancer Res; 1989; 9(4):1185-90. PubMed ID: 2817800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture.
    Bartholeyns J; Lombard Y; Poindron P
    Anticancer Res; 1988; 8(1):145-51. PubMed ID: 3358630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
    Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
    J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
    Remels L; Fransen L; Huygen K; De Baetselier P
    J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.
    Bartholeyns J; Lombard Y; Dumont S; Hartmann D; Chokry M; Giaimis J; Kaufmann S; Poindron P
    Cancer Detect Prev; 1988; 12(1-6):413-20. PubMed ID: 3180139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumoral properties and reduced toxicity of LPS targeted to macrophages via normal or mannosylated liposomes.
    Dumont S; Muller CD; Schuber F; Bartholeyns J
    Anticancer Res; 1990; 10(1):155-60. PubMed ID: 2334121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factor.
    Agah R; Malloy B; Sherrod A; Bean P; Girgis E; Mazumder A
    J Biol Response Mod; 1988 Apr; 7(2):140-51. PubMed ID: 3258905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
    Hori K; Ehrke MJ; Mace K; Mihich E
    Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
    Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
    Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system.
    Inagawa H; Nishizawa T; Noguchi K; Minamimura M; Takagi K; Goto S; Soma G; Mizuno D
    Anticancer Res; 1997; 17(3C):2153-8. PubMed ID: 9216680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newcastle disease virus activates macrophages for anti-tumor activity.
    Schirrmacher V; Bai L; Umansky V; Yu L; Xing Y; Qian Z
    Int J Oncol; 2000 Feb; 16(2):363-73. PubMed ID: 10639582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
    J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice].
    Moriya N
    Nihon Geka Gakkai Zasshi; 1985 Nov; 86(11):1470-9. PubMed ID: 3908902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of macrophage cytotoxicity through endogenous interferon and tumor necrosis factor alpha induction by propanil.
    Theus SA; Tabor DR; Gandy J; Barnett JB
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):46-52. PubMed ID: 7679225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effects of alkylphosphocholines or alkylphosphocholine-liposomes and macrophages on tumor cells.
    Zeisig R; Jungmann S; Fichtner I; Daemen T; Arndt D
    Anticancer Res; 1994; 14(5A):1785-9. PubMed ID: 7847811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.
    Ding AH; Nathan CF
    J Immunol; 1987 Sep; 139(6):1971-7. PubMed ID: 3040860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
    Lin JY; Seguin R; Keller K; Chadee K
    Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.